CIPLA vs DCAL: Stock Comparison

CIPLA vs DISHMAN CARBO AMCISUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

CIPLA is the larger company by market capitalisation. CIPLA shows a lower P/E, a higher ROE and a higher dividend yield, while DISHMAN CARBO AMCIS shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

CIPLA leads 9; DCAL leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

CIPLADCAL

Valuation lens

What price are you paying?

Market CapContext only
₹1.12 L Cr
₹2,723 Cr
P/E RatioCIPLA has the lower reading
33.86x
172.04x
P/B RatioDCAL has the lower reading
3.32x
0.42x
EPSCIPLA has the higher reading
₹10.67
₹-1.53
Book ValueContext only
₹427.31
₹425.87
Dividend YieldCIPLA has the higher reading
0.94%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
CIPLA is the larger company
₹1.12 L Cr vs ₹2,723 Cr
P/E Ratio
CIPLA has a lower P/E
33.86x vs 172.04x
P/B Ratio
DCAL has a lower P/B
0.42x vs 3.32x
EPS
CIPLA has higher earnings per share
₹10.67 vs ₹-1.53
Dividend Yield
CIPLA has a higher dividend yield
0.94% vs 0%
Revenue Growth (TTM YoY)
DCAL has faster revenue growth
18.9% vs -2.1%
EPS Growth (TTM YoY)
DCAL has faster EPS growth
-49.5% vs -54.6%
Qtr Sales Growth
CIPLA has stronger quarterly sales growth
-28.68% vs -91.58%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricCIPLADCAL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricCIPLADCAL
Live Price₹1,385₹174.38
Day Change-0.7%-1.47%
Volume13.26 L1.23 L
52-Week High₹1,673₹321.95
52-Week Low₹1,165.7₹128.5
Distance from 52W High-17.21%-45.84%

Valuation

MetricCIPLADCAL
Market Cap₹1.12 L Cr₹2,723 Cr
P/E Ratio33.86x172.04x
P/B Ratio3.32x0.42x
EPS₹10.67₹-1.53
Book Value₹427.31₹425.87
Dividend Yield0.94%0%

Growth

MetricCIPLADCAL
Revenue Growth (TTM YoY)-2.1%18.9%
EPS Growth (TTM YoY)-54.6%-49.5%
Qtr Sales Growth-28.68%-91.58%
Qtr Profit Growth9.75%58.69%

Profitability & Leverage

MetricCIPLADCAL
ROE10.28%1.46%
ROCE10.09%1.52%
Net Margin13.96%2.51%
Operating Margin24.53%9.52%
Debt to Equity0x0.42x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricCIPLADCAL
Promoter Holding9.17%59.32%
FII Holding20.21% 2.35 pp6.86% 0.59 pp
DII Holding34.63% 2.66 pp2.07% 0.44 pp
Public Holding15.94% 0.31 pp31.75% 0.15 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: CIPLA and DISHMAN CARBO AMCIS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.